When either RANBP9 shRNA-knockdown or CRISPR-KO NSCLC cells were generated, we previously reported that, in general, the expression of RANBP10 was greater than that in parental cells (Fig. 1A-1B, Supplementary Fig. 1 C) [8, 12, 44]. The gene discussed is RANBP10; the disease is non-small cell lung carcinoma.